Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal platelet-rich plasma for treatment of Hori's nevus (pilot study)
TCTR20230113001Phase 2Unknown
- Sponsor
- St John's Institute of Dermatology
- Start
- Nov 2022
- Countries
- 1
01
Overview
A Phase 2 trial of platelet-rich plasma in Oculodermal melanocytosis (ODM), sponsored by St John's Institute of Dermatology. Status: unknown.
02
Drugs
platelet-rich plasma
03
Conditions
Oculodermal melanocytosis (ODM)
Beyond the preview
Go deeper on TCTR20230113001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230113001.